- Home
- VIOT vs KZIA Comparison
VIOT vs KZIA Comparison
Compare VIOT & KZIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VIOT | KZIA |
|---|---|---|
| Founded | 2014 | 1994 |
| Country | China | Australia |
| Employees | N/A | N/A |
| Industry | Consumer Electronics/Appliances | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 87.0M | 100.8M |
| IPO Year | 2018 | 2002 |
Fundamental Metrics
Financial Performance| Metric | VIOT | KZIA |
|---|---|---|
| Price | $1.08 | $10.20 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $17.67 |
| AVG Volume (30 Days) | ★ 297.2K | 153.1K |
| Earning Date | 03-25-2026 | 11-07-2025 |
| Dividend Yield | ★ 11.58% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $9.04 | N/A |
| P/E Ratio | $3.56 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.92 | $2.86 |
| 52 Week High | $4.33 | $17.40 |
Technical Indicators
Market Signals| Indicator | VIOT | KZIA |
|---|---|---|
| Relative Strength Index (RSI) | 42.31 | 68.55 |
| Support Level | N/A | $5.74 |
| Resistance Level | $1.50 | $10.92 |
| Average True Range (ATR) | 0.09 | 0.96 |
| MACD | 0.01 | 0.22 |
| Stochastic Oscillator | 51.71 | 76.10 |
Price Performance
Historical ComparisonAbout VIOT Viomi Technology Co. Ltd
Viomi Technology Co Ltd, along with its subsidiaries, specializes in the development and sale of Internet-of-Things-enabled smart home products, particularly focusing on home water solutions. The company markets its products in China and generates the majority of its revenue through the sale of smart water purification systems and other connected home devices designed to improve convenience and automation in residential settings. Its product offerings include water purification products, water heaters, smart water kettles, electric kettles, water filters, range hoods, gas stoves, and other small appliances.
About KZIA Kazia Therapeutics Limited
Kazia Therapeutics Ltd is a biotechnology company focused on pharmaceutical drug development in oncology. The company has a portfolio of development candidates across various technologies targeting multiple cancer indications. Its primary program is Paxalisib, an investigational brain-penetrant inhibitor of the PI3K/Akt/mTOR pathway, designed for the treatment of brain cancer. The company develops targeted therapies aimed at addressing medical needs in oncology. The company operates in Australia and the United States.